Intellipharmaceutics International (IPCIF) Stock Chart & Stock Price History Add Compare Share Share Chart Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Intellipharmaceutics International Stock Price Performance 5 Day Performance-100.00%1 Month Performance-100.00%3 Month Performance-100.00%6 Month Performance-100.00%Year-To-Date Performance-100.00%1 Year Performance-100.00% Receive IPCIF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter. Email Address IPCIF Stock Chart for Saturday, April, 12, 2025 IPCIF Chart by TradingViewRemove Ads Intellipharmaceutics International Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel No price data in the selected date range. Related Companies GRCE Stock Chart ENLV Stock Chart RVPH Stock Chart IMUC Stock Chart NAII Stock Chart HPPI Stock Chart CDIO Stock Chart OVID Stock Chart ANVS Stock Chart PMN Stock Chart Receive IPCIF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:IPCIF) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersAnother tariff shock is coming (how to prepare)There's a new way to make money from Trump's Trade War… without predicting which way the market will move. ...Brownstone Research | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMillions of Americans are going to be shocked as soon as May 31Worried About the Market? See This Immediately... While CNBC and the Wall Street Journal are focused on Lib...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellipharmaceutics International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellipharmaceutics International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.